Form D · Other
BonDia Labs, Inc.
Kentfield, CA · CIK 0001496081
Offering snapshot reported Jul 12, 2010 · SEC filing
- Reported sold
- $3.81M Offering amount: $3.81M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $24.2K Reported outside-investor minimum
- First sale
- Jul 8, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 12, 2010 | Initial | $3,811,330 | No comparison | 15 | SEC filing |
| Jul 7, 2010 | Initial | $896 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144695
Issuer agreed to issue 2,628,504 shares of common stock in merger transaction. Total offering amount based on price of acquired company's common stock ($1.45 per share) sold to outside investors prior to merger. No proceeds were received by Issuer.
Source: Form D, filed Jul 12, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Caden | Director, Executive |
| Duncan Seay | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
19 Toussin Avenue
Kentfield, CA, 94904
Kentfield, CA, 94904